A phase II study of sequence-dependent docetaxel (D)/vinorelbine(V) DNA damage-induced apoptosis in patients with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Balana, C [1 ]
Monzo, M [1 ]
Martin, C [1 ]
Lopez, MP [1 ]
Nunez, L [1 ]
Rosell, R [1 ]
机构：
[1] Hosp Germans Trias & Pujol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
482
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [1] A phase II study of 3 sequence-dependent docetaxel (D)/vinorelbine(V) DNA damage-induced apoptosis in patients with non-small cell lung cancer (NSCLC)
    Balañá, C
    Martín, C
    Rosell, R
    Monzó, M
    Manzano, JL
    Guillot, M
    Font, K
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S66 - S66
  • [2] Phase II study of sequence-dependent docetaxel (D)/vinorelbine (V) in patients (p) with advanced non-small cell lung cancer (NSCLC).
    Sánchez, JM
    Balañá, C
    Font, A
    Guillot, M
    Manzano, J
    Margelí, M
    Sánchez, JJ
    Aracil, C
    Rosell, R
    ANNALS OF ONCOLOGY, 2000, 11 : 122 - 122
  • [3] A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer
    Rosell, R
    Felip, E
    Massuti, B
    GonzalezLarriba, JL
    Benito, D
    LopezCabrerizo, MP
    Salamanca, O
    Camps, C
    PuertoPica, J
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 56 - 60
  • [4] A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer
    Bennouna, J
    Monnier, A
    Rivière, A
    Milleron, B
    Lemarie, E
    Trillet-Lenoir, V
    Soussan-Lazard, K
    Berille, J
    Douillard, JY
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (09) : 1107 - 1112
  • [5] First line treatment of non-small cell lung carcinoma (NSCLC) with docetaxel and vinorelbine: A phase II study
    Kourousis, C
    Androulakis, N
    Kakolyris, S
    Vamvakas, L
    Heras, P
    Metaxaris, G
    Maltezakis, G
    Chalkiadakis, G
    Vlachonikolis, J
    Hatzidaki, D
    Samonis, G
    Georgoulias, V
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 673 - 679
  • [6] Sequence-Dependent Antiproliferative Effects of Gefitinib and Docetaxel on Non-Small Cell Lung Cancer (NSCLC) Cells and the Possible Mechanism
    Chen, Bei
    Zheng, Jingxian
    Zeng, Yunyun
    Li, Baofeng
    Xie, Bo
    Zheng, Jihua
    Zhou, Juan
    Zhang, Weimin
    PLOS ONE, 2014, 9 (12):
  • [7] Phase I/II study of exisulind (E) and vinorelbine (V) in elderly patients with advanced non-small cell lung cancer (NSCLC).
    Traynor, AM
    Merchant, JJ
    Hoang, T
    Ahuja, HG
    Beatty, PA
    Hansen, RM
    Masters, GA
    Oettel, KR
    Shapiro, GR
    Schiller, JH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 684S - 684S
  • [8] Docetaxel (D) and vinorelbine (V) in non-small cell lung cancer (NSCLC) previously treated with cisplatin-based chemotherapy:: A phase II trial.
    Muñoz, A
    Rubio, I
    Mañé, JM
    Ferreiro, J
    Fernández, R
    Fuente, N
    Abón, G
    López-Argumedo, G
    Barceló, R
    Vivanco, GL
    ANNALS OF ONCOLOGY, 2000, 11 : 117 - 117
  • [9] A phase II Study of administration of Docetaxel and Vinorelbine with Gemcitabine for inoperable Stage III or IV Non-Small Cell Lung Cancer (NSCLC)
    Reza, Md S.
    Hai, Mohammad A.
    Chowdhury, Qamruzzaman
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S708 - S709
  • [10] A phase II study of vinorelbine in patients with advanced non-small cell lung cancer
    Evans, TRJ
    Mansi, JL
    Morgan, DAL
    Gyi, KM
    Banham, SW
    Milroy, R
    ONCOLOGY REPORTS, 1997, 4 (06) : 1337 - 1341
12345